Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

NGAL (rat), mAb (15)

BPD-ABS-039-15-02 200 µg 690.00 USD
BPD-ABS-039-15-1 1 mg 3,100.00 USD

Product Specification

Alternative Name:Neutrophil gelatinase-associated lipocalin, Lipocalin 2, Siderocalin, Oncogene 24p3
Immunogen:Recombinant rat NGAL precursor.
UniProt ID:P30152
Species reactivity:Rat
Recommended Dilutions/Conditions:ELISA (1:10,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~25kDa by Western blot.
Purity Detail:Protein A/G-affinity purified.
Formulation:Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide.
Short Term Storage:+4°C
Long Term Storage:+4°C
Miscellaneous/General:Rat lipocalin-2 is also called rat NGAL, as it is the ortholog of human neutrophil gelatinase-associated lipocalin (NGAL). Rat NGAL is a 25kDa α2-microglobulin-related protein or neu-related lipocalin. It is expressed by neutrophils and various epithelial cells, including cells of the renal proximal tubules. It is involved in physiological processes such as the binding of siderophore iron and tissue growth and regeneration. It is upregulated in a variety of pathological situations including infection, inflammation, ischemia-reperfusion and in certain adenocarcinomas.

General Literature References

Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics: D. Burt, et al.; Drug Chem. Toxicol. 37, 204 (2014), Abstract;
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury: J. Mishra, et al.; J. Am. Soc. Nephrol. 14, 2534 (2003), Abstract;

Related Literature

Product Flyers
Monitor programmed cell death from membrane to nucleus
Monitor programmed cell death from membrane to nucleus 10-Feb-14
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2014 Enzo Life Sciences, Inc.,